nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—P-Glycoprotein Inhibitors—Vemurafenib—melanoma	0.702	1	CiPCiCtD
Ticagrelor—ABCB1—melanoma	0.14	1	CbGaD
Ticagrelor—CYP3A4—Temozolomide—melanoma	0.0381	0.376	CbGbCtD
Ticagrelor—ABCB1—Dactinomycin—melanoma	0.0232	0.229	CbGbCtD
Ticagrelor—CYP3A4—Vemurafenib—melanoma	0.0209	0.206	CbGbCtD
Ticagrelor—ABCB1—Docetaxel—melanoma	0.012	0.118	CbGbCtD
Ticagrelor—CYP3A4—Docetaxel—melanoma	0.00717	0.0708	CbGbCtD
Ticagrelor—Non-cardiac chest pain—Docetaxel—melanoma	0.00141	0.041	CcSEcCtD
Ticagrelor—Haemorrhage intracranial—Temozolomide—melanoma	0.000897	0.026	CcSEcCtD
Ticagrelor—Neoplasm malignant—Vemurafenib—melanoma	0.000844	0.0245	CcSEcCtD
Ticagrelor—Nephropathy toxic—Bleomycin—melanoma	0.00076	0.022	CcSEcCtD
Ticagrelor—Transient ischaemic attack—Temozolomide—melanoma	0.00073	0.0212	CcSEcCtD
Ticagrelor—Cerebral haemorrhage—Carmustine—melanoma	0.000688	0.02	CcSEcCtD
Ticagrelor—Cerebral haemorrhage—Temozolomide—melanoma	0.000665	0.0193	CcSEcCtD
Ticagrelor—Nephropathy toxic—Carmustine—melanoma	0.000663	0.0192	CcSEcCtD
Ticagrelor—Atrial fibrillation—Vemurafenib—melanoma	0.000552	0.016	CcSEcCtD
Ticagrelor—Lung disorder—Temozolomide—melanoma	0.00052	0.0151	CcSEcCtD
Ticagrelor—Vaginal haemorrhage—Temozolomide—melanoma	0.000497	0.0144	CcSEcCtD
Ticagrelor—Petechiae—Temozolomide—melanoma	0.000447	0.013	CcSEcCtD
Ticagrelor—Oedema peripheral—Vemurafenib—melanoma	0.000356	0.0103	CcSEcCtD
Ticagrelor—Connective tissue disorder—Vemurafenib—melanoma	0.000355	0.0103	CcSEcCtD
Ticagrelor—Gynaecomastia—Carmustine—melanoma	0.000341	0.00989	CcSEcCtD
Ticagrelor—Eye disorder—Vemurafenib—melanoma	0.000338	0.00981	CcSEcCtD
Ticagrelor—Cardiac disorder—Vemurafenib—melanoma	0.000336	0.00974	CcSEcCtD
Ticagrelor—Angiopathy—Vemurafenib—melanoma	0.000328	0.00952	CcSEcCtD
Ticagrelor—Mediastinal disorder—Vemurafenib—melanoma	0.000326	0.00946	CcSEcCtD
Ticagrelor—Malnutrition—Vemurafenib—melanoma	0.000315	0.00914	CcSEcCtD
Ticagrelor—Back pain—Vemurafenib—melanoma	0.000305	0.00884	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Carmustine—melanoma	0.000277	0.00802	CcSEcCtD
Ticagrelor—Cough—Vemurafenib—melanoma	0.000275	0.00797	CcSEcCtD
Ticagrelor—Bone disorder—Docetaxel—melanoma	0.000271	0.00786	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000266	0.00773	CcSEcCtD
Ticagrelor—Oliguria—Docetaxel—melanoma	0.000266	0.00771	CcSEcCtD
Ticagrelor—Nervous system disorder—Vemurafenib—melanoma	0.000252	0.00731	CcSEcCtD
Ticagrelor—Skin disorder—Vemurafenib—melanoma	0.00025	0.00724	CcSEcCtD
Ticagrelor—Breast disorder—Temozolomide—melanoma	0.000242	0.00701	CcSEcCtD
Ticagrelor—Hypotension—Vemurafenib—melanoma	0.00024	0.00697	CcSEcCtD
Ticagrelor—Haematuria—Bleomycin—melanoma	0.000233	0.00675	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Vemurafenib—melanoma	0.000222	0.00644	CcSEcCtD
Ticagrelor—Fatigue—Vemurafenib—melanoma	0.000222	0.00643	CcSEcCtD
Ticagrelor—Haemoglobin—Bleomycin—melanoma	0.00022	0.00639	CcSEcCtD
Ticagrelor—Constipation—Vemurafenib—melanoma	0.00022	0.00638	CcSEcCtD
Ticagrelor—Haemorrhage—Bleomycin—melanoma	0.000219	0.00636	CcSEcCtD
Ticagrelor—Body temperature increased—Vemurafenib—melanoma	0.000203	0.0059	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Docetaxel—melanoma	0.000196	0.00569	CcSEcCtD
Ticagrelor—Haemoglobin—Carmustine—melanoma	0.000192	0.00558	CcSEcCtD
Ticagrelor—Haemorrhage—Carmustine—melanoma	0.000191	0.00555	CcSEcCtD
Ticagrelor—Hypersensitivity—Vemurafenib—melanoma	0.000189	0.00549	CcSEcCtD
Ticagrelor—Oedema peripheral—Carmustine—melanoma	0.000188	0.00547	CcSEcCtD
Ticagrelor—Connective tissue disorder—Carmustine—melanoma	0.000188	0.00545	CcSEcCtD
Ticagrelor—Atrial fibrillation—Docetaxel—melanoma	0.000188	0.00544	CcSEcCtD
Ticagrelor—Haemoglobin—Temozolomide—melanoma	0.000186	0.00539	CcSEcCtD
Ticagrelor—Haemorrhage—Temozolomide—melanoma	0.000185	0.00536	CcSEcCtD
Ticagrelor—Asthenia—Vemurafenib—melanoma	0.000184	0.00535	CcSEcCtD
Ticagrelor—Urinary tract disorder—Temozolomide—melanoma	0.000183	0.0053	CcSEcCtD
Ticagrelor—Oedema peripheral—Temozolomide—melanoma	0.000182	0.00528	CcSEcCtD
Ticagrelor—Cardiac failure—Docetaxel—melanoma	0.000182	0.00528	CcSEcCtD
Ticagrelor—Pruritus—Vemurafenib—melanoma	0.000182	0.00528	CcSEcCtD
Ticagrelor—Connective tissue disorder—Temozolomide—melanoma	0.000182	0.00527	CcSEcCtD
Ticagrelor—Urethral disorder—Temozolomide—melanoma	0.000181	0.00526	CcSEcCtD
Ticagrelor—Eye disorder—Carmustine—melanoma	0.000179	0.00519	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000178	0.00516	CcSEcCtD
Ticagrelor—Diarrhoea—Vemurafenib—melanoma	0.000176	0.0051	CcSEcCtD
Ticagrelor—Eye disorder—Temozolomide—melanoma	0.000173	0.00501	CcSEcCtD
Ticagrelor—Cardiac disorder—Temozolomide—melanoma	0.000172	0.00498	CcSEcCtD
Ticagrelor—Dizziness—Vemurafenib—melanoma	0.00017	0.00493	CcSEcCtD
Ticagrelor—Angiopathy—Temozolomide—melanoma	0.000168	0.00487	CcSEcCtD
Ticagrelor—Mental disorder—Carmustine—melanoma	0.000168	0.00486	CcSEcCtD
Ticagrelor—Immune system disorder—Temozolomide—melanoma	0.000167	0.00485	CcSEcCtD
Ticagrelor—Mediastinal disorder—Temozolomide—melanoma	0.000167	0.00483	CcSEcCtD
Ticagrelor—Malnutrition—Carmustine—melanoma	0.000167	0.00483	CcSEcCtD
Ticagrelor—Cough—Bleomycin—melanoma	0.000166	0.00483	CcSEcCtD
Ticagrelor—Vomiting—Vemurafenib—melanoma	0.000163	0.00474	CcSEcCtD
Ticagrelor—Chest pain—Bleomycin—melanoma	0.000162	0.00471	CcSEcCtD
Ticagrelor—Rash—Vemurafenib—melanoma	0.000162	0.0047	CcSEcCtD
Ticagrelor—Mental disorder—Temozolomide—melanoma	0.000162	0.0047	CcSEcCtD
Ticagrelor—Dermatitis—Vemurafenib—melanoma	0.000162	0.0047	CcSEcCtD
Ticagrelor—Back pain—Carmustine—melanoma	0.000161	0.00467	CcSEcCtD
Ticagrelor—Headache—Vemurafenib—melanoma	0.000161	0.00467	CcSEcCtD
Ticagrelor—Malnutrition—Temozolomide—melanoma	0.000161	0.00467	CcSEcCtD
Ticagrelor—Breast disorder—Docetaxel—melanoma	0.000161	0.00466	CcSEcCtD
Ticagrelor—Confusional state—Bleomycin—melanoma	0.000157	0.00456	CcSEcCtD
Ticagrelor—Back pain—Temozolomide—melanoma	0.000156	0.00452	CcSEcCtD
Ticagrelor—Nausea—Vemurafenib—melanoma	0.000153	0.00443	CcSEcCtD
Ticagrelor—Angioedema—Temozolomide—melanoma	0.000147	0.00427	CcSEcCtD
Ticagrelor—Hypotension—Bleomycin—melanoma	0.000146	0.00422	CcSEcCtD
Ticagrelor—Vertigo—Temozolomide—melanoma	0.000145	0.0042	CcSEcCtD
Ticagrelor—Hypertension—Carmustine—melanoma	0.000144	0.00417	CcSEcCtD
Ticagrelor—Chest pain—Carmustine—melanoma	0.000142	0.00411	CcSEcCtD
Ticagrelor—Cough—Temozolomide—melanoma	0.00014	0.00407	CcSEcCtD
Ticagrelor—Paraesthesia—Bleomycin—melanoma	0.00014	0.00406	CcSEcCtD
Ticagrelor—Hypertension—Temozolomide—melanoma	0.000139	0.00403	CcSEcCtD
Ticagrelor—Dyspnoea—Bleomycin—melanoma	0.000139	0.00403	CcSEcCtD
Ticagrelor—Confusional state—Carmustine—melanoma	0.000137	0.00398	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000136	0.00395	CcSEcCtD
Ticagrelor—Confusional state—Temozolomide—melanoma	0.000132	0.00384	CcSEcCtD
Ticagrelor—Epistaxis—Docetaxel—melanoma	0.000129	0.00375	CcSEcCtD
Ticagrelor—Nervous system disorder—Temozolomide—melanoma	0.000129	0.00374	CcSEcCtD
Ticagrelor—Feeling abnormal—Bleomycin—melanoma	0.000128	0.00372	CcSEcCtD
Ticagrelor—Skin disorder—Temozolomide—melanoma	0.000128	0.0037	CcSEcCtD
Ticagrelor—Hypotension—Carmustine—melanoma	0.000127	0.00369	CcSEcCtD
Ticagrelor—Fatigue—Dactinomycin—melanoma	0.000125	0.00363	CcSEcCtD
Ticagrelor—Haemoglobin—Docetaxel—melanoma	0.000124	0.00359	CcSEcCtD
Ticagrelor—Body temperature increased—Bleomycin—melanoma	0.000123	0.00357	CcSEcCtD
Ticagrelor—Haemorrhage—Docetaxel—melanoma	0.000123	0.00357	CcSEcCtD
Ticagrelor—Paraesthesia—Carmustine—melanoma	0.000122	0.00354	CcSEcCtD
Ticagrelor—Urinary tract disorder—Docetaxel—melanoma	0.000121	0.00352	CcSEcCtD
Ticagrelor—Dyspnoea—Carmustine—melanoma	0.000121	0.00352	CcSEcCtD
Ticagrelor—Oedema peripheral—Docetaxel—melanoma	0.000121	0.00351	CcSEcCtD
Ticagrelor—Connective tissue disorder—Docetaxel—melanoma	0.000121	0.00351	CcSEcCtD
Ticagrelor—Urethral disorder—Docetaxel—melanoma	0.000121	0.0035	CcSEcCtD
Ticagrelor—Feeling abnormal—Dactinomycin—melanoma	0.00012	0.00347	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dactinomycin—melanoma	0.000119	0.00345	CcSEcCtD
Ticagrelor—Paraesthesia—Temozolomide—melanoma	0.000118	0.00342	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Carmustine—melanoma	0.000117	0.0034	CcSEcCtD
Ticagrelor—Dyspnoea—Temozolomide—melanoma	0.000117	0.0034	CcSEcCtD
Ticagrelor—Constipation—Carmustine—melanoma	0.000116	0.00337	CcSEcCtD
Ticagrelor—Dyspepsia—Temozolomide—melanoma	0.000116	0.00335	CcSEcCtD
Ticagrelor—Eye disorder—Docetaxel—melanoma	0.000115	0.00333	CcSEcCtD
Ticagrelor—Abdominal pain—Dactinomycin—melanoma	0.000115	0.00333	CcSEcCtD
Ticagrelor—Body temperature increased—Dactinomycin—melanoma	0.000115	0.00333	CcSEcCtD
Ticagrelor—Hypersensitivity—Bleomycin—melanoma	0.000115	0.00333	CcSEcCtD
Ticagrelor—Cardiac disorder—Docetaxel—melanoma	0.000114	0.00331	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Temozolomide—melanoma	0.000113	0.00329	CcSEcCtD
Ticagrelor—Fatigue—Temozolomide—melanoma	0.000113	0.00329	CcSEcCtD
Ticagrelor—Constipation—Temozolomide—melanoma	0.000112	0.00326	CcSEcCtD
Ticagrelor—Feeling abnormal—Carmustine—melanoma	0.000112	0.00325	CcSEcCtD
Ticagrelor—Asthenia—Bleomycin—melanoma	0.000112	0.00324	CcSEcCtD
Ticagrelor—Angiopathy—Docetaxel—melanoma	0.000112	0.00324	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Carmustine—melanoma	0.000111	0.00322	CcSEcCtD
Ticagrelor—Immune system disorder—Docetaxel—melanoma	0.000111	0.00322	CcSEcCtD
Ticagrelor—Mediastinal disorder—Docetaxel—melanoma	0.000111	0.00322	CcSEcCtD
Ticagrelor—Pruritus—Bleomycin—melanoma	0.00011	0.0032	CcSEcCtD
Ticagrelor—Feeling abnormal—Temozolomide—melanoma	0.000108	0.00314	CcSEcCtD
Ticagrelor—Mental disorder—Docetaxel—melanoma	0.000108	0.00313	CcSEcCtD
Ticagrelor—Abdominal pain—Carmustine—melanoma	0.000107	0.00312	CcSEcCtD
Ticagrelor—Body temperature increased—Carmustine—melanoma	0.000107	0.00312	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Temozolomide—melanoma	0.000107	0.00312	CcSEcCtD
Ticagrelor—Malnutrition—Docetaxel—melanoma	0.000107	0.00311	CcSEcCtD
Ticagrelor—Hypersensitivity—Dactinomycin—melanoma	0.000107	0.0031	CcSEcCtD
Ticagrelor—Asthenia—Dactinomycin—melanoma	0.000104	0.00302	CcSEcCtD
Ticagrelor—Abdominal pain—Temozolomide—melanoma	0.000104	0.00301	CcSEcCtD
Ticagrelor—Body temperature increased—Temozolomide—melanoma	0.000104	0.00301	CcSEcCtD
Ticagrelor—Back pain—Docetaxel—melanoma	0.000104	0.003	CcSEcCtD
Ticagrelor—Hypersensitivity—Carmustine—melanoma	0.0001	0.00291	CcSEcCtD
Ticagrelor—Diarrhoea—Dactinomycin—melanoma	9.94e-05	0.00288	CcSEcCtD
Ticagrelor—Vomiting—Bleomycin—melanoma	9.9e-05	0.00287	CcSEcCtD
Ticagrelor—Rash—Bleomycin—melanoma	9.82e-05	0.00285	CcSEcCtD
Ticagrelor—Dermatitis—Bleomycin—melanoma	9.81e-05	0.00285	CcSEcCtD
Ticagrelor—Asthenia—Carmustine—melanoma	9.75e-05	0.00283	CcSEcCtD
Ticagrelor—Hypersensitivity—Temozolomide—melanoma	9.68e-05	0.00281	CcSEcCtD
Ticagrelor—Syncope—Docetaxel—melanoma	9.6e-05	0.00278	CcSEcCtD
Ticagrelor—Asthenia—Temozolomide—melanoma	9.42e-05	0.00273	CcSEcCtD
Ticagrelor—Loss of consciousness—Docetaxel—melanoma	9.41e-05	0.00273	CcSEcCtD
Ticagrelor—Cough—Docetaxel—melanoma	9.34e-05	0.00271	CcSEcCtD
Ticagrelor—Diarrhoea—Carmustine—melanoma	9.3e-05	0.0027	CcSEcCtD
Ticagrelor—Pruritus—Temozolomide—melanoma	9.29e-05	0.0027	CcSEcCtD
Ticagrelor—Nausea—Bleomycin—melanoma	9.25e-05	0.00268	CcSEcCtD
Ticagrelor—Hypertension—Docetaxel—melanoma	9.24e-05	0.00268	CcSEcCtD
Ticagrelor—Vomiting—Dactinomycin—melanoma	9.23e-05	0.00268	CcSEcCtD
Ticagrelor—Rash—Dactinomycin—melanoma	9.16e-05	0.00266	CcSEcCtD
Ticagrelor—Chest pain—Docetaxel—melanoma	9.11e-05	0.00264	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	9.05e-05	0.00263	CcSEcCtD
Ticagrelor—Dizziness—Carmustine—melanoma	8.99e-05	0.00261	CcSEcCtD
Ticagrelor—Diarrhoea—Temozolomide—melanoma	8.99e-05	0.00261	CcSEcCtD
Ticagrelor—Confusional state—Docetaxel—melanoma	8.81e-05	0.00256	CcSEcCtD
Ticagrelor—Dizziness—Temozolomide—melanoma	8.69e-05	0.00252	CcSEcCtD
Ticagrelor—Vomiting—Carmustine—melanoma	8.64e-05	0.00251	CcSEcCtD
Ticagrelor—Nausea—Dactinomycin—melanoma	8.63e-05	0.0025	CcSEcCtD
Ticagrelor—Shock—Docetaxel—melanoma	8.59e-05	0.00249	CcSEcCtD
Ticagrelor—Rash—Carmustine—melanoma	8.57e-05	0.00249	CcSEcCtD
Ticagrelor—Nervous system disorder—Docetaxel—melanoma	8.57e-05	0.00249	CcSEcCtD
Ticagrelor—Dermatitis—Carmustine—melanoma	8.56e-05	0.00248	CcSEcCtD
Ticagrelor—Headache—Carmustine—melanoma	8.51e-05	0.00247	CcSEcCtD
Ticagrelor—Skin disorder—Docetaxel—melanoma	8.48e-05	0.00246	CcSEcCtD
Ticagrelor—Vomiting—Temozolomide—melanoma	8.35e-05	0.00242	CcSEcCtD
Ticagrelor—Rash—Temozolomide—melanoma	8.28e-05	0.0024	CcSEcCtD
Ticagrelor—Dermatitis—Temozolomide—melanoma	8.27e-05	0.0024	CcSEcCtD
Ticagrelor—Headache—Temozolomide—melanoma	8.23e-05	0.00239	CcSEcCtD
Ticagrelor—Hypotension—Docetaxel—melanoma	8.16e-05	0.00237	CcSEcCtD
Ticagrelor—Nausea—Carmustine—melanoma	8.07e-05	0.00234	CcSEcCtD
Ticagrelor—Paraesthesia—Docetaxel—melanoma	7.84e-05	0.00228	CcSEcCtD
Ticagrelor—Nausea—Temozolomide—melanoma	7.8e-05	0.00226	CcSEcCtD
Ticagrelor—Dyspnoea—Docetaxel—melanoma	7.79e-05	0.00226	CcSEcCtD
Ticagrelor—Dyspepsia—Docetaxel—melanoma	7.69e-05	0.00223	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Docetaxel—melanoma	7.54e-05	0.00219	CcSEcCtD
Ticagrelor—Fatigue—Docetaxel—melanoma	7.53e-05	0.00219	CcSEcCtD
Ticagrelor—Constipation—Docetaxel—melanoma	7.47e-05	0.00217	CcSEcCtD
Ticagrelor—Feeling abnormal—Docetaxel—melanoma	7.2e-05	0.00209	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Docetaxel—melanoma	7.14e-05	0.00207	CcSEcCtD
Ticagrelor—Body temperature increased—Docetaxel—melanoma	6.91e-05	0.002	CcSEcCtD
Ticagrelor—Abdominal pain—Docetaxel—melanoma	6.91e-05	0.002	CcSEcCtD
Ticagrelor—Hypersensitivity—Docetaxel—melanoma	6.44e-05	0.00187	CcSEcCtD
Ticagrelor—Asthenia—Docetaxel—melanoma	6.27e-05	0.00182	CcSEcCtD
Ticagrelor—Pruritus—Docetaxel—melanoma	6.18e-05	0.00179	CcSEcCtD
Ticagrelor—Diarrhoea—Docetaxel—melanoma	5.98e-05	0.00173	CcSEcCtD
Ticagrelor—Dizziness—Docetaxel—melanoma	5.78e-05	0.00168	CcSEcCtD
Ticagrelor—Vomiting—Docetaxel—melanoma	5.55e-05	0.00161	CcSEcCtD
Ticagrelor—Rash—Docetaxel—melanoma	5.51e-05	0.0016	CcSEcCtD
Ticagrelor—Dermatitis—Docetaxel—melanoma	5.5e-05	0.0016	CcSEcCtD
Ticagrelor—Headache—Docetaxel—melanoma	5.47e-05	0.00159	CcSEcCtD
Ticagrelor—Nausea—Docetaxel—melanoma	5.19e-05	0.00151	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—PIK3CD—melanoma	2.94e-05	0.00127	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HDAC6—melanoma	2.9e-05	0.00126	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—melanoma	2.9e-05	0.00125	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—EDN1—melanoma	2.87e-05	0.00124	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	2.86e-05	0.00124	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CSF2—melanoma	2.81e-05	0.00122	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	2.75e-05	0.00119	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCR2—melanoma	2.75e-05	0.00119	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL8—melanoma	2.75e-05	0.00119	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RAC2—melanoma	2.71e-05	0.00117	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PRKCA—melanoma	2.69e-05	0.00117	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFC—melanoma	2.66e-05	0.00115	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—WNT5A—melanoma	2.66e-05	0.00115	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EDN1—melanoma	2.61e-05	0.00113	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	2.59e-05	0.00112	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CB—melanoma	2.56e-05	0.00111	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CSF2—melanoma	2.55e-05	0.0011	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IFNG—melanoma	2.54e-05	0.0011	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	2.5e-05	0.00108	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—RAC1—melanoma	2.5e-05	0.00108	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—AKT1—melanoma	2.47e-05	0.00107	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PRKCA—melanoma	2.45e-05	0.00106	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—MDM2—melanoma	2.4e-05	0.00104	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAP2K2—melanoma	2.39e-05	0.00103	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL8—melanoma	2.36e-05	0.00102	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IL2—melanoma	2.35e-05	0.00102	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—F2R—melanoma	2.34e-05	0.00101	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—RAC1—melanoma	2.27e-05	0.000981	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDNRB—melanoma	2.27e-05	0.00098	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CASP3—melanoma	2.26e-05	0.000978	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL2—melanoma	2.26e-05	0.000976	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	2.25e-05	0.000972	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	2.22e-05	0.000958	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTK2B—melanoma	2.2e-05	0.000951	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GAB2—melanoma	2.14e-05	0.000925	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GNA11—melanoma	2.14e-05	0.000925	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FLT1—melanoma	2.13e-05	0.000921	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP17A1—melanoma	2.12e-05	0.000918	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CG—melanoma	2.11e-05	0.000913	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	2.11e-05	0.000912	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	2.09e-05	0.000906	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	2.06e-05	0.000892	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	2.04e-05	0.000883	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	2.02e-05	0.000874	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FOXO4—melanoma	2.01e-05	0.00087	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCR4—melanoma	2.01e-05	0.00087	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HDAC2—melanoma	2.01e-05	0.00087	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—melanoma	2e-05	0.000864	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GNAQ—melanoma	1.99e-05	0.00086	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	1.98e-05	0.000857	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NRAS—melanoma	1.97e-05	0.000853	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	1.95e-05	0.000841	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACER3—melanoma	1.93e-05	0.000836	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—melanoma	1.92e-05	0.00083	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CG—melanoma	1.92e-05	0.000829	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	1.91e-05	0.000827	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MAPK3—melanoma	1.89e-05	0.000817	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	1.87e-05	0.00081	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SYK—melanoma	1.87e-05	0.000809	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CD—melanoma	1.85e-05	0.000802	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT3—melanoma	1.84e-05	0.000794	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ITGAV—melanoma	1.84e-05	0.000794	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NGFR—melanoma	1.84e-05	0.000794	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MAPK1—melanoma	1.8e-05	0.000777	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—CYP1B1—melanoma	1.79e-05	0.000773	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	1.78e-05	0.00077	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—UGT2B10—melanoma	1.77e-05	0.000765	CbGpPWpGaD
Ticagrelor—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	1.76e-05	0.000762	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SOCS1—melanoma	1.7e-05	0.000735	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—KRAS—melanoma	1.7e-05	0.000734	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAP2K1—melanoma	1.7e-05	0.000733	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—S100B—melanoma	1.7e-05	0.000733	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	1.69e-05	0.00073	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CD—melanoma	1.68e-05	0.000729	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	1.68e-05	0.000727	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—melanoma	1.64e-05	0.000711	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HS3ST5—melanoma	1.64e-05	0.000711	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB4—melanoma	1.62e-05	0.000701	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CB—melanoma	1.62e-05	0.000699	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN2B—melanoma	1.61e-05	0.000695	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	1.58e-05	0.000685	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	1.56e-05	0.000677	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PIK3CA—melanoma	1.56e-05	0.000675	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD86—melanoma	1.55e-05	0.000672	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL8—melanoma	1.55e-05	0.000672	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EDN1—melanoma	1.54e-05	0.000667	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TP53—melanoma	1.51e-05	0.000653	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CSF2—melanoma	1.51e-05	0.000652	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGF1—melanoma	1.51e-05	0.000652	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2—melanoma	1.48e-05	0.000642	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—E2F1—melanoma	1.48e-05	0.000638	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	1.47e-05	0.000638	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CB—melanoma	1.47e-05	0.000635	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PDGFRA—melanoma	1.46e-05	0.000631	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	1.45e-05	0.000627	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRKCA—melanoma	1.45e-05	0.000625	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ITGB3—melanoma	1.45e-05	0.000625	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—HRAS—melanoma	1.44e-05	0.000624	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SPP1—melanoma	1.42e-05	0.000613	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	1.41e-05	0.000611	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAP2K2—melanoma	1.41e-05	0.000611	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL8—melanoma	1.41e-05	0.00061	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	1.4e-05	0.000606	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL2—melanoma	1.35e-05	0.000583	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TERT—melanoma	1.34e-05	0.000581	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RAC1—melanoma	1.34e-05	0.000579	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.33e-05	0.000576	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HIF1A—melanoma	1.28e-05	0.000556	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—AKT1—melanoma	1.27e-05	0.000551	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.27e-05	0.000547	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.25e-05	0.000539	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLCB4—melanoma	1.25e-05	0.000539	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.23e-05	0.000532	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KDR—melanoma	1.23e-05	0.000531	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.2e-05	0.00052	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACER3—melanoma	1.19e-05	0.000515	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FN1—melanoma	1.18e-05	0.000512	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC6A11—melanoma	1.17e-05	0.000507	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIP4K2A—melanoma	1.17e-05	0.000507	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOTCH1—melanoma	1.16e-05	0.000501	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.14e-05	0.000495	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTAP—melanoma	1.14e-05	0.000493	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.14e-05	0.000492	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD80—melanoma	1.13e-05	0.00049	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—APC—melanoma	1.13e-05	0.00049	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CG—melanoma	1.13e-05	0.00049	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KIT—melanoma	1.13e-05	0.00049	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—NRAS—melanoma	1.13e-05	0.00049	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGF—melanoma	1.12e-05	0.000484	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.12e-05	0.000483	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—UGT2B10—melanoma	1.09e-05	0.000471	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.09e-05	0.00047	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAPK3—melanoma	1.08e-05	0.000469	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.08e-05	0.000465	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BRAF—melanoma	1.06e-05	0.00046	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.05e-05	0.000454	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.05e-05	0.000453	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.04e-05	0.000451	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IGF1—melanoma	1.04e-05	0.000448	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MAPK1—melanoma	1.03e-05	0.000446	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—EGFR—melanoma	1.03e-05	0.000446	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LUM—melanoma	1.02e-05	0.000439	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PHGDH—melanoma	1.02e-05	0.000439	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HS3ST5—melanoma	1.01e-05	0.000438	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAP2K1—melanoma	1e-05	0.000433	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—HPSE—melanoma	9.96e-06	0.000431	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CD—melanoma	9.95e-06	0.00043	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PIK3CA—melanoma	9.86e-06	0.000426	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CUBN—melanoma	9.78e-06	0.000423	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—KRAS—melanoma	9.74e-06	0.000421	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FGF2—melanoma	9.53e-06	0.000412	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	9.47e-06	0.000409	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SDHD—melanoma	9.44e-06	0.000408	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BSG—melanoma	9.44e-06	0.000408	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CSPG4—melanoma	9.44e-06	0.000408	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GPAM—melanoma	9.14e-06	0.000395	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	8.96e-06	0.000387	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PIK3CA—melanoma	8.95e-06	0.000387	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MDM2—melanoma	8.91e-06	0.000386	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ERBB2—melanoma	8.79e-06	0.00038	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	8.71e-06	0.000377	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CB—melanoma	8.67e-06	0.000375	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	8.52e-06	0.000369	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	8.52e-06	0.000369	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—melanoma	8.33e-06	0.00036	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—HRAS—melanoma	8.28e-06	0.000358	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1B—melanoma	8.14e-06	0.000352	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	8.11e-06	0.000351	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AKT1—melanoma	8.05e-06	0.000348	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	8.05e-06	0.000348	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CASP3—melanoma	7.98e-06	0.000345	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2—melanoma	7.97e-06	0.000345	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—melanoma	7.93e-06	0.000343	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLA2G6—melanoma	7.77e-06	0.000336	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCND1—melanoma	7.76e-06	0.000336	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CTNNB1—melanoma	7.69e-06	0.000333	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLCB4—melanoma	7.68e-06	0.000332	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—melanoma	7.54e-06	0.000326	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDKN1A—melanoma	7.51e-06	0.000325	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTEN—melanoma	7.49e-06	0.000324	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NFKB1—melanoma	7.46e-06	0.000323	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	7.39e-06	0.00032	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AKT1—melanoma	7.31e-06	0.000316	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIP4K2A—melanoma	7.22e-06	0.000312	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC6A11—melanoma	7.22e-06	0.000312	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	7.15e-06	0.000309	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTAP—melanoma	7.02e-06	0.000304	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—VCAN—melanoma	6.98e-06	0.000302	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—melanoma	6.77e-06	0.000293	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT3—melanoma	6.7e-06	0.00029	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NRAS—melanoma	6.69e-06	0.000289	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK3—melanoma	6.4e-06	0.000277	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PHGDH—melanoma	6.26e-06	0.000271	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LUM—melanoma	6.26e-06	0.000271	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MYC—melanoma	6.23e-06	0.000269	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—HPSE—melanoma	6.14e-06	0.000265	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK1—melanoma	6.09e-06	0.000264	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—EGFR—melanoma	6.09e-06	0.000263	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.04e-06	0.000261	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CUBN—melanoma	6.02e-06	0.00026	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP17A1—melanoma	5.89e-06	0.000255	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SDHD—melanoma	5.82e-06	0.000252	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BSG—melanoma	5.82e-06	0.000252	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CSPG4—melanoma	5.82e-06	0.000252	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—KRAS—melanoma	5.75e-06	0.000249	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GPAM—melanoma	5.63e-06	0.000244	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GNA11—melanoma	5.56e-06	0.000241	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	5.46e-06	0.000236	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FASN—melanoma	5.45e-06	0.000236	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC5A5—melanoma	5.36e-06	0.000232	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PIK3CA—melanoma	5.29e-06	0.000229	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GNAQ—melanoma	5.17e-06	0.000224	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CD44—melanoma	5.17e-06	0.000224	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TP53—melanoma	5.11e-06	0.000221	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CYP1B1—melanoma	4.96e-06	0.000215	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HRAS—melanoma	4.89e-06	0.000212	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLA2G6—melanoma	4.79e-06	0.000207	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—melanoma	4.68e-06	0.000202	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AKT1—melanoma	4.32e-06	0.000187	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—VCAN—melanoma	4.3e-06	0.000186	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PRKCA—melanoma	3.76e-06	0.000163	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ERCC2—melanoma	3.73e-06	0.000161	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP17A1—melanoma	3.63e-06	0.000157	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GNA11—melanoma	3.43e-06	0.000148	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FASN—melanoma	3.35e-06	0.000145	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC5A5—melanoma	3.3e-06	0.000143	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CD44—melanoma	3.19e-06	0.000138	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GNAQ—melanoma	3.19e-06	0.000138	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CYP1B1—melanoma	3.06e-06	0.000132	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CG—melanoma	2.94e-06	0.000127	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARG—melanoma	2.84e-06	0.000123	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CD—melanoma	2.59e-06	0.000112	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—melanoma	2.55e-06	0.000111	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCB1—melanoma	2.52e-06	0.000109	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PRKCA—melanoma	2.32e-06	0.0001	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ERCC2—melanoma	2.3e-06	9.93e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CB—melanoma	2.26e-06	9.76e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—melanoma	2.24e-06	9.67e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTEN—melanoma	1.95e-06	8.43e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CG—melanoma	1.81e-06	7.85e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARG—melanoma	1.75e-06	7.57e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CD—melanoma	1.59e-06	6.9e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—melanoma	1.57e-06	6.81e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CB—melanoma	1.39e-06	6.01e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—melanoma	1.38e-06	5.96e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PIK3CA—melanoma	1.38e-06	5.95e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTEN—melanoma	1.2e-06	5.19e-05	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AKT1—melanoma	1.12e-06	4.86e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PIK3CA—melanoma	8.47e-07	3.66e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AKT1—melanoma	6.92e-07	2.99e-05	CbGpPWpGaD
